Diagnosis of vasculitis

Best Practice and Research: Clinical Rheumatology

Volumn 15, Issue 2, 2001, Pages 203-223

  Mohan, Niveditha ^a   Kerr, Gail S ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ANCA; Angiography; Biopsy; Diagnosis; Non invasive imaging; Vasculitis

Indexed keywords

ALLOPURINOL; AMPHETAMINE; AZATHIOPRINE; AZITHROMYCIN; CAPTOPRIL; CARBIMAZOLE; CIMETIDINE; COCAINE; CYTARABINE; DECONGESTIVE AGENT; DIAMORPHINE; HYDRALAZINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; MINOCYCLINE; MONOCLONAL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; PENICILLIN DERIVATIVE; PHENYLPROPANOLAMINE; PROPYLTHIOURACIL; PYRAZOLONE DERIVATIVE; QUINOLONE DERIVATIVE; STREPTOKINASE; SULFONAMIDE; THIAMAZOLE; THIAZIDE DIURETIC AGENT; ZAFIRLUKAST;

ANGIOGRAPHY; BIOPSY; CARDIOVASCULAR INFLAMMATION; CLINICAL FEATURE; CLINICAL PRACTICE; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG FORMULATION; HISTOLOGY; HUMAN; NON INVASIVE MEASUREMENT; PHYSICAL EXAMINATION; PILL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEROLOGY; VASCULITIS;

EID: 0034990827     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2000.0140     Document Type: Article

References (57)

1. The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction
2. Nomenclature of systemic vasculitides. Proposal of an international consensus conference
3. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis
4. A prospective study of vasculitis patients collected in a five year period: Evaluation of the Chapel Hill nomenclature
5. Testicular vasculitis: Implications for systemic disease
6. Localized vasculitis of the gastrointestinal tract
7. Familial vasculitis: Report of 2 families
8. Cogan's syndrome with refractory abdominal aortitis and mesenteric vasculitis
9. Gastrointestinal emergencies: Vasculitis and the gut
10. The clinical neuro-ophthalmologic spectrum of temporal arteritis
11. Avascular areas in nailfold capillary microscopy of patients with Wegener's granulomatosis
12. Diagnosis and evaluation of vasculitis
13. Idiopathic and secondary vasculitis: A review
14. Sarcoidosis and systemic vasculitis
15. The spectrum of vasculitis in HIV-infected patients
16. Small-vessel vasculitis
17. Phenylpropanolamine: An over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage
18. Treatment of corticosteroid-resistant giant cell arteritis
19. Takayasu arteritis
20. Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity
21. Von Willebrand factor in the outcome of temporal arteritis
22. YKL-40 in giant cells and macrophages from patients with GCA
23. Circulating soluble adhesion molecules in patients with giant cell arteritis; correlation between soluble intercellular adhesion molecule-I (sICAM-1) concentrations and disease activity
24. Anti-endothelial cell antibodies in Takayasu arteritis
25. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides
26. Vasculitis of the central nervous system
27. International consensus statement on testing and reporting of ANCA
28. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis
29. Evolving concepts about the role of antineutrophil cytoplasm autoantibodies in systemic vasculitides
30. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies
31. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis
32. Development of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA): A report on the second phase of an international cooperative study on the standardization of ANCA assays
33. The diagnostic value of standardized assays for ANCA in idiopathic systemic vasculitis: Results of an international collaborative study
34. Serial measurements of antineutrophil cytoplasmic antibodies in patients with systemic vasculitis
35. Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis
36. Illustrated histopathologic classification criteria or selected vasculitis syndromes
37. The therapeutic impact of temporal artery biopsy
38. Systemic manifestations of TA: The expanding spectrum
39. Percutaneous image-guided biopsy of lung nodules in the assessment of disease activity in WG
40. Vasculitis of the central nervous system
41. Takayasu arteritis: Protean radiologic manifestations and diagnosis
42. Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis
43. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: A study of 43 patients
44. Color duplex ultrasonography in the diagnosis of temporal arteritis
45. Conventional and CT angiographic diagnosis of TA
46. Pulmonary Wegener's granulomatosis: Correlation between high-resolution CT findings and clinical scoring of disease activity
47. Gadolinium contrast magnetic resonance imaging of the temporal artery in giant cell arteritis
48. TA in Thailand: Clinical and imaging features
49. The clinical application of 'edema-weighted' magnetic resonance imaging in the assessment of Takayasu's arteritis
50. Classification and histopathologic spectrum of central nervous system vasculitis
51. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch
52. Nuclear medicine in vasculitis
53. The role of gallium scintigraphy, CT scan and MRI in the diagnosis of Takayasu's disease
54. Temporal gallium uptake is increased in temporal arteritis
55. 99m-Tc-HMPAO-SPECT in diagnosis of early cerebral vasculitis
56. Vasculitis in the central nervous system
57. Comparison of 201 TISPET and treadmill exercise testing in patients with Kawasaki disease